Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies

ConditionMyopathy
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-70
SponsorUniversity of Sao Paulo

About this trial

Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.

Eligibility criteria

Qualifiers

Classification criteria - EULAR/ACR 2017

Classification critera - Connors et al.

Disqualifiers

Neoplasia

Using heart pacemarker

Using visceral metalic clips

Infections (HIV, HTLV-1, Hepatitis, etc)

Trial design

Treatments tested in this trial

  • Chronic transcranial direct current stimulation

Treatment groups

40 Participants
are divided into 2 treatment groups

Sponsors and collaborators